Melissa M Camouse, DO
Dermatology · Torrance
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
- Since medical school
- 24 years
- Lake Erie College of Osteopathic Medicine, Erie, 2002
Offices
2 locations · Malcolm Ke MD A Professional Corporation · 6 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Camouse’s office to ask if they take your plan before you enroll.
Original Medicare doctor bills
$468,342
Medicare paid this office $468,342 for 1,434 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 941 | $103,634 | $70 |
| Return visit (30+ min) | 449 | $67,449 | $98 |
| Destruction of precancer skin growth, 1 growth | 729 | $51,029 | $46 |
| Biopsy of related skin growth, first growth | 406 | $43,827 | $80 |
| Destruction of skin growth, 1-14 growths | 321 | $40,525 | $93 |
See all 22 services
| Short return visit (20+ min) | 941 | $103,634 | $70 |
| Return visit (30+ min) | 449 | $67,449 | $98 |
| Destruction of precancer skin growth, 1 growth | 729 | $51,029 | $46 |
| Biopsy of related skin growth, first growth | 406 | $43,827 | $80 |
| Destruction of skin growth, 1-14 growths | 321 | $40,525 | $93 |
| Destruction of precancer skin growth, 2-14 growths | 601 | $24,915 | $6 |
| Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | 47 | $16,718 | None |
| Destruction of precancer skin growth, 15 or more growths | 89 | $15,617 | $141 |
| New patient visit (30+ min) | 192 | $14,583 | $76 |
| New patient visit (45+ min) | 116 | $13,574 | $117 |
| Application of light with debridement to destroy precancer skin growth | 44 | $12,939 | $240 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 29 | $9,273 | $265 |
| Short return visit | 149 | $8,028 | $45 |
| Biopsy of related skin growth, each additional growth | 102 | $6,844 | $46 |
| Punch biopsy, first skin growth | 33 | $3,296 | $100 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 23 | $2,858 | $110 |
| Injection into skin growth, 1-7 growths | 40 | $2,542 | $44 |
| Biopsy of ear | 28 | $1,885 | $59 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 11 | $1,667 | $128 |
| New patient visit (15+ min) | 27 | $1,295 | $48 |
| Pathology examination of tissue using a microscope, intermediate complexity | 19 | $805 | $32 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 45 | $58 | None |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 28 | More than 79% of doctors who do this |
| Removal of skin cancer | 89 | More than 21% of doctors who do this |
| Removal of skin lesions | 2474 | More than 99% of doctors who do this |
| Removal of tissue | 1-10 | None |
| Removal or shaving of skin growth | 1-10 | None |
| Skin biopsy | 740 | More than 98% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | 1,458 | 1,676 | 2,657 | 3,300 | 3,370 | 4,249 |
| Destruction of precancer skin growth, 1 growth | 405 | 435 | 680 | 892 | 965 | 1,103 |
| Biopsy of related skin growth, first growth | 287 | 281 | 369 | 475 | 495 | 549 |
| Destruction of skin growth, 1-14 growths | 97 | 104 | 173 | 332 | 342 | 436 |
| Biopsy of related skin growth, each additional growth | 100 | 89 | 118 | 162 | 118 | 150 |
| Destruction of precancer skin growth, 15 or more growths | 19 | 63 | 82 | 121 | 101 | 111 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
1,434 Original Medicare patients in 2024. Average age 74 · Under 65 3% · 85 and older 11% · Women 55% · Also on Medicaid 13% · Health risk score 0.98. At or below the middle of the specialty; the typical dermatology clinician is at 1.01.
Conditions among them: High blood pressure 65% · Coronary heart disease 23% · Diabetes 22% · Chronic kidney disease 18% · Cancer 16% · Atrial fibrillation 14% · Depression 13% · Heart failure 10% · COPD 9% · Stroke 6% · Dementia 4%.
The office billed $1,258,257, Medicare allowed $648,400 and paid $468,342; for 22,738 services of 70 kinds; $16,776 of it was for drugs given in the office and $451,566 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,434 | 22,738 | 74 | 0.98 | $1,258,257 | $468,342 |
| 2023 | 1,236 | 20,196 | 74 | 0.98 | $1,049,223 | $413,397 |
| 2022 | 1,037 | 17,905 | 75 | 0.98 | $747,638 | $378,613 |
| 2021 | 757 | 16,738 | 74 | 0.93 | $540,105 | $284,958 |
| 2020 | 548 | 7,182 | 74 | 0.98 | $352,218 | $167,702 |
| 2019 | 501 | 13,812 | 75 | 1.01 | $352,733 | $170,574 |
| 2018 | 385 | 8,928 | 75 | 1.01 | $511,529 | $124,077 |
| 2017 | 248 | 1,627 | 75 | 0.99 | $157,750 | $73,519 |
| 2016 | 171 | 1,229 | 75 | 0.99 | $106,720 | $49,489 |
| 2015 | 157 | 1,435 | 76 | 1.15 | $116,939 | $52,764 |
| 2014 | 148 | 1,098 | 77 | 1.08 | $87,320 | $39,487 |
| 2013 | 189 | 1,296 | 77 | 1.08 | $112,340 | $51,231 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 21 services
| Short return visit (20+ min) | 757 | $84,836 | $70 |
| Return visit (30+ min) | 378 | $66,315 | $101 |
| Destruction of precancer skin growth, 1 growth | 622 | $45,670 | $47 |
| Biopsy of related skin growth, first growth | 396 | $42,047 | $85 |
| Destruction of skin growth, 1-14 growths | 274 | $33,567 | $98 |
| Destruction of precancer skin growth, 2-14 growths | 499 | $20,529 | $6 |
| New patient visit (30+ min) | 237 | $19,266 | $81 |
| Destruction of precancer skin growth, 15 or more growths | 75 | $15,280 | $151 |
| Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | 44 | $15,052 | None |
| Application of light with debridement to destroy precancer skin growth | 45 | $14,876 | $256 |
| New patient visit (45+ min) | 105 | $12,121 | $115 |
| Short return visit | 108 | $5,645 | $47 |
| Biopsy of related skin growth, each additional growth | 92 | $5,452 | $46 |
| Punch biopsy, first skin growth | 35 | $3,894 | $111 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 12 | $3,239 | $270 |
| Injection into skin growth, 1-7 growths | 56 | $3,052 | $41 |
| Biopsy of ear | 23 | $1,856 | $74 |
| New patient visit (15+ min) | 24 | $1,424 | $59 |
| Long return visit (40+ min) | 11 | $1,204 | $109 |
| Pathology examination of tissue using a microscope, intermediate complexity | 20 | $749 | $33 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 35 | $44 | None |
2022: 21 services
| Short return visit (20+ min) | 613 | $67,127 | $71 |
| Return visit (30+ min) | 382 | $65,429 | $104 |
| Destruction of precancer skin growth, 1 growth | 536 | $40,537 | $45 |
| Biopsy of related skin growth, first growth | 373 | $39,213 | $83 |
| Destruction of skin growth, 1-14 growths | 250 | $32,862 | $99 |
| Destruction of precancer skin growth, 2-14 growths | 438 | $20,221 | $6 |
| Destruction of precancer skin growth, 15 or more growths | 90 | $18,035 | $149 |
| New patient visit (30+ min) | 175 | $14,901 | $85 |
| Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | 34 | $12,613 | None |
| Application of light with debridement to destroy precancer skin growth | 34 | $12,586 | $252 |
| New patient visit (45+ min) | 88 | $11,614 | $132 |
| Biopsy of related skin growth, each additional growth | 103 | $7,565 | $47 |
| Short return visit | 131 | $7,235 | $46 |
| Punch biopsy, first skin growth | 46 | $5,286 | $110 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 14 | $4,293 | $268 |
| Biopsy of ear | 30 | $1,947 | $63 |
| Injection into skin growth, 1-7 growths | 29 | $1,919 | $42 |
| Simple or single drainage of skin abscess | 15 | $1,678 | $99 |
| New patient visit (15+ min) | 28 | $1,483 | $53 |
| Pathology examination of tissue using a microscope, intermediate complexity | 18 | $872 | $31 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 13 | $25 | None |
2021: 19 services
| Short return visit (20+ min) | 424 | $48,749 | $74 |
| Return visit (30+ min) | 263 | $45,280 | $108 |
| Biopsy of related skin growth, first growth | 287 | $33,070 | $90 |
| Destruction of precancer skin growth, 1 growth | 422 | $31,760 | $47 |
| Destruction of skin growth, 1-14 growths | 134 | $17,608 | $102 |
| Destruction of precancer skin growth, 2-14 growths | 361 | $16,027 | $6 |
| Application of light with debridement to destroy precancer skin growth | 41 | $14,911 | $271 |
| Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | 40 | $13,444 | None |
| Destruction of precancer skin growth, 15 or more growths | 58 | $12,249 | $149 |
| New patient visit (30+ min) | 117 | $9,295 | $79 |
| New patient visit (45+ min) | 57 | $7,982 | $140 |
| Short return visit | 104 | $5,919 | $46 |
| Biopsy of related skin growth, each additional growth | 80 | $5,805 | $49 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 15 | $5,176 | $272 |
| Punch biopsy, first skin growth | 17 | $2,201 | $122 |
| Injection into skin growth, 1-7 growths | 25 | $1,800 | $43 |
| Simple or single drainage of skin abscess | 16 | $1,711 | $107 |
| Biopsy of ear | 19 | $1,529 | $73 |
| New patient visit (15+ min) | 23 | $1,377 | $60 |
2020: 17 services
| Return visit (30+ min) | 266 | $32,572 | $85 |
| Biopsy of related skin growth, first growth | 228 | $24,080 | $86 |
| Short return visit (20+ min) | 263 | $23,065 | $60 |
| Destruction of precancer skin growth, 1 growth | 312 | $19,284 | $44 |
| Destruction of skin growth, 1-14 growths | 84 | $10,261 | $99 |
| New patient visit (30+ min) | 109 | $10,033 | $92 |
| Destruction of precancer skin growth, 2-14 growths | 259 | $9,414 | $6 |
| Destruction of precancer skin growth, 15 or more growths | 50 | $9,143 | $145 |
| Biopsy of related skin growth, each additional growth | 66 | $4,357 | $49 |
| Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | 16 | $4,103 | None |
| Application of light with debridement to destroy precancer skin growth | 14 | $3,561 | $254 |
| New patient visit (15+ min) | 59 | $3,364 | $57 |
| Punch biopsy, first skin growth | 17 | $2,115 | $111 |
| Biopsy of ear | 16 | $1,319 | $73 |
| Short return visit | 18 | $701 | $39 |
| Injection into skin growth, 1-7 growths | 18 | $607 | $28 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 18 | $28 | None |
2019: 19 services
| Return visit (30+ min) | 224 | $28,358 | $89 |
| Short return visit (20+ min) | 250 | $24,902 | $63 |
| Biopsy of related skin growth, first growth | 206 | $23,721 | $83 |
| Destruction of precancer skin growth, 1 growth | 259 | $18,205 | $45 |
| Application of light with debridement to destroy precancer skin growth | 28 | $11,867 | $237 |
| Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | 28 | $11,401 | None |
| Destruction of skin growth, 1-14 growths | 79 | $9,397 | $97 |
| Destruction of precancer skin growth, 2-14 growths | 213 | $7,366 | $5 |
| New patient visit (30+ min) | 75 | $5,984 | $80 |
| Biopsy of related skin growth, each additional growth | 65 | $4,867 | $49 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 13 | $4,146 | $276 |
| New patient visit (15+ min) | 53 | $3,364 | $63 |
| Destruction of precancer skin growth, 15 or more growths | 14 | $2,605 | $137 |
| Punch biopsy, first skin growth | 18 | $2,051 | $108 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 11 | $1,684 | $130 |
| Short return visit | 31 | $1,414 | $37 |
| Biopsy of ear | 17 | $1,069 | $59 |
| Injection into skin growth, 1-7 growths | 12 | $440 | $31 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 12 | $19 | None |
2018: 16 services
| Return visit (30+ min) | 163 | $20,080 | $89 |
| Biopsy of single growth of skin and/or tissue | 167 | $18,436 | $87 |
| Short return visit (20+ min) | 162 | $18,124 | $61 |
| Destruction of precancer skin growth, 1 growth | 202 | $14,240 | $45 |
| Application of light with debridement to destroy precancer skin growth | 26 | $8,812 | $220 |
| Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | 27 | $6,980 | None |
| Destruction of skin growth, 1-14 growths | 58 | $6,177 | $97 |
| Destruction of precancer skin growth, 2-14 growths | 168 | $5,599 | $5 |
| New patient visit (30+ min) | 63 | $5,072 | $81 |
| Destruction of precancer skin growth, 15 or more growths | 20 | $3,075 | $128 |
| New patient visit (15+ min) | 45 | $2,156 | $48 |
| Biopsy of each additional growth of skin and/or tissue | 47 | $1,993 | $28 |
| Short return visit | 27 | $1,048 | $37 |
| Biopsy of ear | 11 | $997 | $71 |
| Injection into skin growth, 1-7 growths | 15 | $604 | $32 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 16 | $33 | None |
2017: 10 services
| Return visit (30+ min) | 102 | $12,928 | $84 |
| Short return visit (20+ min) | 99 | $9,041 | $59 |
| Biopsy of single growth of skin and/or tissue | 86 | $8,967 | $81 |
| Destruction of precancer skin growth, 1 growth | 115 | $8,942 | $46 |
| Destruction of skin growth, 1-14 growths | 37 | $4,330 | $94 |
| Destruction of precancer skin growth, 2-14 growths | 87 | $3,251 | $5 |
| New patient visit (30+ min) | 38 | $3,116 | $82 |
| Pathology examination of tissue using a microscope, intermediate complexity | 39 | $1,593 | $33 |
| New patient visit (15+ min) | 26 | $1,083 | $42 |
| Biopsy of each additional growth of skin and/or tissue | 22 | $800 | $29 |
2016: 11 services
| Return visit (30+ min) | 75 | $8,595 | $83 |
| Short return visit (20+ min) | 78 | $6,937 | $59 |
| Destruction of precancer skin growth, 1 growth | 95 | $6,740 | $45 |
| Biopsy of single growth of skin and/or tissue | 60 | $5,837 | $85 |
| Destruction of skin growth, 1-14 growths | 28 | $3,415 | $92 |
| Destruction of precancer skin growth, 2-14 growths | 79 | $2,788 | $5 |
| New patient visit (30+ min) | 20 | $1,564 | $78 |
| New patient visit (15+ min) | 21 | $1,277 | $61 |
| Short return visit | 21 | $911 | $35 |
| Injection into skin growth, 1-7 growths | 12 | $417 | $28 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 12 | $18 | None |
2015: 14 services
| Biopsy of single growth of skin and/or tissue | 80 | $8,036 | $80 |
| Short return visit (20+ min) | 86 | $7,194 | $56 |
| Destruction of precancer skin growth, 1 growth | 93 | $6,579 | $42 |
| Return visit (30+ min) | 60 | $6,217 | $84 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 20 | $4,621 | None |
| Destruction of precancer skin growth, 2-14 growths | 81 | $3,621 | $5 |
| Application of light to destroy precancer skin growth | 19 | $2,247 | $118 |
| Destruction of skin growth, 1-14 growths | 21 | $2,178 | $95 |
| New patient visit (30+ min) | 18 | $1,308 | $73 |
| New patient visit (15+ min) | 20 | $897 | $45 |
| Biopsy of each additional growth of skin and/or tissue | 22 | $856 | $28 |
| Short return visit | 16 | $776 | $34 |
| Injection into skin growth, 1-7 growths | 13 | $391 | $30 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 13 | $20 | None |
2014: 10 services
| Destruction of precancer skin growth, 1 growth | 85 | $5,977 | $49 |
| Short return visit (20+ min) | 76 | $5,543 | $52 |
| Biopsy of single growth of skin and/or tissue | 51 | $5,091 | $80 |
| Destruction of precancer skin growth, 2-14 growths | 68 | $5,054 | $9 |
| Destruction of skin growth, 1-14 growths | 25 | $3,167 | $93 |
| New patient visit (30+ min) | 28 | $2,097 | $75 |
| New patient visit (15+ min) | 32 | $1,666 | $52 |
| Return visit (30+ min) | 14 | $1,312 | $82 |
| Short return visit | 30 | $1,296 | $35 |
| Biopsy of each additional growth of skin and/or tissue | 13 | $527 | $28 |
2013: 12 services
| Biopsy of single growth of skin and/or tissue | 79 | $8,270 | $87 |
| Destruction of precancer skin growth, 1 growth | 97 | $7,349 | $54 |
| Short return visit (20+ min) | 78 | $5,712 | $55 |
| New patient visit (15+ min) | 94 | $5,377 | $57 |
| New patient visit (30+ min) | 51 | $4,172 | $82 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 14 | $3,779 | $270 |
| Destruction of precancer skin growth, 2-14 growths | 81 | $3,557 | $6 |
| Destruction of skin growth, 1-14 growths | 22 | $2,083 | $91 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 12 | $1,226 | $102 |
| Biopsy of each additional growth of skin and/or tissue | 27 | $1,056 | $27 |
| Short return visit | 21 | $1,018 | $36 |
| Injection into skin growth, 1-7 growths | 11 | $439 | $34 |
Medicaid work
$407,480 in 2024
Medicaid paid $407,480 for 11,369 billed services this clinician did in 2024, up to 650 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 6,820 | $235,185 |
| New patient visit (45+ min) | 1,623 | $95,889 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions | 637 | $36,048 |
| Tangential biopsy of skin (eg, shave, scoop, saucerize, curette); single lesion | 359 | $16,314 |
| Injection, intralesional; up to and including 7 lesions | 642 | $10,998 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 319 | $3,799 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); first lesion | 53 | $2,614 |
| Punch biopsy of skin (including simple closure, when performed); single lesion | 29 | $2,069 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 688 | $2,028 |
| New patient visit (60+ min) | 12 | $1,138 |
| New patient visit (30+ min) | 13 | $396 |
| Short return visit | 13 | $351 |
| 2024 | 11,369 | 14 | 650 | $407,480 |
| 2023 | 15,125 | 18 | 754 | $534,184 |
| 2022 | 14,008 | 18 | 710 | $374,447 |
| 2021 | 11,029 | 15 | 584 | $300,276 |
| 2020 | 6,304 | 10 | 328 | $177,290 |
| 2019 | 4,797 | 13 | 256 | $132,502 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 9,241 | $316,642 |
| New patient visit (45+ min) | 1,694 | $97,014 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions | 836 | $45,410 |
| Tangential biopsy of skin (eg, shave, scoop, saucerize, curette); single lesion | 524 | $29,567 |
| New patient visit (60+ min) | 220 | $12,023 |
| Injection, intralesional; up to and including 7 lesions | 820 | $11,511 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); first lesion | 109 | $5,156 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 320 | $4,567 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 940 | $3,850 |
| Punch biopsy of skin (including simple closure, when performed); single lesion | 39 | $3,405 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); second through 14 lesions, each (List separately in addition to code for first lesion) | 82 | $1,429 |
| INTMD RPR S/A/T/EXT 2.6-7.5 | 12 | $773 |
2022
| Return visit (30+ min) | 8,318 | $198,776 |
| New patient visit (45+ min) | 1,263 | $54,053 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions | 799 | $37,227 |
| Tangential biopsy of skin (eg, shave, scoop, saucerize, curette); single lesion | 575 | $26,587 |
| New patient visit (60+ min) | 234 | $13,904 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 371 | $12,632 |
| Injection, intralesional; up to and including 7 lesions | 740 | $8,734 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 981 | $4,974 |
| Punch biopsy of skin (including simple closure, when performed); single lesion | 70 | $4,587 |
| Injection, intralesional; more than 7 lesions | 219 | $3,477 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 186 | $3,345 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); first lesion | 41 | $1,891 |
2021
| Return visit (30+ min) | 6,433 | $155,724 |
| New patient visit (45+ min) | 1,006 | $42,401 |
| Tangential biopsy of skin (eg, shave, scoop, saucerize, curette); single lesion | 546 | $26,146 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions | 665 | $25,346 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 451 | $16,141 |
| New patient visit (60+ min) | 233 | $12,698 |
| Injection, intralesional; up to and including 7 lesions | 584 | $7,319 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 773 | $4,418 |
| Punch biopsy of skin (including simple closure, when performed); single lesion | 57 | $3,315 |
| Injection, intralesional; more than 7 lesions | 137 | $2,201 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 39 | $1,379 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); first lesion | 41 | $1,296 |
2020
| Return visit (30+ min) | 3,575 | $86,800 |
| New patient visit (45+ min) | 640 | $27,897 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 537 | $17,796 |
| Tangential biopsy of skin (eg, shave, scoop, saucerize, curette); single lesion | 340 | $16,197 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions | 381 | $16,082 |
| New patient visit (60+ min) | 55 | $3,543 |
| Injection, intralesional; up to and including 7 lesions | 302 | $2,760 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 57 | $2,234 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 386 | $2,076 |
| Punch biopsy of skin (including simple closure, when performed); single lesion | 31 | $1,905 |
2019
| Return visit (30+ min) | 2,106 | $43,310 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 1,142 | $42,380 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions | 354 | $12,901 |
| Tangential biopsy of skin (eg, shave, scoop, saucerize, curette); single lesion | 294 | $11,660 |
| New patient visit (45+ min) | 428 | $10,579 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 122 | $4,475 |
| New patient visit (60+ min) | 58 | $2,876 |
| Punch biopsy of skin (including simple closure, when performed); single lesion | 31 | $1,716 |
| New patient visit (30+ min) | 46 | $692 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); first lesion | 25 | $672 |
| Tangential biopsy of skin (eg, shave, scoop, saucerize, curette); each separate/additional lesion (List separately in addition to code for primary procedure) | 12 | $520 |
| Injection, intralesional; up to and including 7 lesions | 88 | $384 |
Drugs they prescribed that Part D paid
$313,496
Pharmacies billed $313,496 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 480) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.
430 generic and 50 brand-name prescriptions · $313,496 in drug cost · 23 antibiotic prescriptions to 12 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Dupixent | 24 | $97,097 | $4,046 |
| Fluorouracil | 36 | $2,861 | $79 |
| Clobetasol Propionate | 40 | $2,013 | $50 |
| Tretinoin | 13 | $1,114 | $86 |
| Metronidazole | 19 | $1,018 | $54 |
See all 14 drugs
| Dupixent | 24 | $97,097 | $4,046 |
| Fluorouracil | 36 | $2,861 | $79 |
| Clobetasol Propionate | 40 | $2,013 | $50 |
| Tretinoin | 13 | $1,114 | $86 |
| Metronidazole | 19 | $1,018 | $54 |
| Imiquimod | 15 | $963 | $64 |
| Ketoconazole | 38 | $672 | $18 |
| Econazole Nitrate | 27 | $485 | $18 |
| Triamcinolone Acetonide | 85 | $407 | $5 |
| Valacyclovir | 33 | $266 | $8 |
| Fluocinonide | 12 | $245 | $20 |
| Clindamycin Phosphate | 13 | $208 | $16 |
| Mupirocin | 15 | $62 | $4 |
| Hydrocortisone | 12 | $56 | $5 |
Year by year
| 2024 | 480 | 231 | 0% (0) | 10% | $313,496 |
| 2023 | 428 | 229 | 0% (0) | 9% | $128,268 |
| 2022 | 318 | 176 | 0% (0) | None | $15,666 |
| 2021 | 235 | 122 | 0% (0) | None | $10,707 |
| 2020 | 279 | 128 | 0% (0) | 17% | $29,763 |
| 2019 | 201 | 110 | 0% (0) | 16% | $37,568 |
| 2018 | 234 | 116 | 0% (0) | 12% | $18,317 |
| 2017 | 204 | 108 | None | 11% | $17,453 |
| 2016 | 214 | 84 | None | 14% | $24,747 |
| 2015 | 135 | 59 | 0% (0) | 12% | $11,179 |
| 2014 | 159 | 63 | 0% (0) | 12% | $24,548 |
| 2013 | 260 | 108 | None | 20% | $14,292 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Dupixent | 14 | $54,834 | $3,917 |
| Fluorouracil | 22 | $2,101 | $96 |
| Tretinoin | 14 | $1,832 | $131 |
| Clobetasol Propionate | 26 | $1,565 | $60 |
| Fluocinolone Acetonide | 16 | $1,096 | $68 |
| Ketoconazole | 40 | $1,085 | $27 |
| Imiquimod | 13 | $1,075 | $83 |
| Fluocinonide | 20 | $973 | $49 |
| Triamcinolone Acetonide | 82 | $650 | $8 |
| Clindamycin Phosphate | 20 | $597 | $30 |
| Econazole Nitrate | 17 | $453 | $27 |
| Valacyclovir | 20 | $256 | $13 |
| Mupirocin | 12 | $98 | $8 |
| Hydrocortisone | 17 | $84 | $5 |
2022: 9 drugs
| Clobetasol Propionate | 19 | $1,474 | $78 |
| Fluocinolone Acetonide | 16 | $1,430 | $89 |
| Fluorouracil | 17 | $1,361 | $80 |
| Ketoconazole | 37 | $1,315 | $36 |
| Triamcinolone Acetonide | 82 | $849 | $10 |
| Clindamycin Phosphate | 13 | $483 | $37 |
| Fluocinonide | 12 | $469 | $39 |
| Valacyclovir | 17 | $147 | $9 |
| Mupirocin | 11 | $104 | $9 |
2021: 7 drugs
| Fluorouracil | 13 | $988 | $76 |
| Fluocinolone Acetonide | 13 | $983 | $76 |
| Ketoconazole | 32 | $666 | $21 |
| Clobetasol Propionate | 16 | $661 | $41 |
| Valacyclovir | 15 | $334 | $22 |
| Triamcinolone Acetonide | 45 | $333 | $7 |
| Hydrocortisone | 14 | $66 | $5 |
2020: 8 drugs
| Calcipotriene | 29 | $5,095 | $176 |
| Fluorouracil | 15 | $1,242 | $83 |
| Clobetasol Propionate | 23 | $1,224 | $53 |
| Metronidazole | 13 | $1,125 | $87 |
| Triamcinolone Acetonide | 57 | $592 | $10 |
| Ketoconazole | 17 | $503 | $30 |
| Clindamycin Phosphate | 20 | $366 | $18 |
| Valacyclovir | 18 | $292 | $16 |
2019: 5 drugs
| Clobetasol Propionate | 12 | $848 | $71 |
| Valacyclovir | 17 | $357 | $21 |
| Triamcinolone Acetonide | 46 | $326 | $7 |
| Ketoconazole | 16 | $323 | $20 |
| Mupirocin | 14 | $84 | $6 |
2018: 7 drugs
| Tretinoin | 26 | $2,459 | $95 |
| Fluorouracil | 13 | $1,933 | $149 |
| Clobetasol Propionate | 18 | $1,662 | $92 |
| Ketoconazole | 15 | $708 | $47 |
| Triamcinolone Acetonide | 53 | $605 | $11 |
| Valacyclovir | 13 | $340 | $26 |
| Mupirocin | 13 | $100 | $8 |
2017: 4 drugs
| Tretinoin | 17 | $1,980 | $116 |
| Clobetasol Propionate | 13 | $1,515 | $117 |
| Triamcinolone Acetonide | 53 | $676 | $13 |
| Clindamycin Phosphate | 11 | $486 | $44 |
2016: 5 drugs
| Clobetasol Propionate | 42 | $8,531 | $203 |
| Tretinoin | 17 | $2,666 | $157 |
| Econazole Nitrate | 11 | $1,902 | $173 |
| Triamcinolone Acetonide | 28 | $469 | $17 |
| Minocycline | 12 | $141 | $12 |
2015: 5 drugs
| Clobetasol Propionate | 14 | $3,949 | $282 |
| Tretinoin | 14 | $1,644 | $117 |
| Fluocinonide | 16 | $1,214 | $76 |
| Ketoconazole | 17 | $283 | $17 |
| Triamcinolone Acetonide | 19 | $243 | $13 |
2014: 6 drugs
| Fluocinonide | 26 | $1,639 | $63 |
| Clobetasol Propionate | 16 | $1,634 | $102 |
| Valacyclovir | 13 | $673 | $52 |
| Econazole Nitrate | 14 | $410 | $29 |
| Triamcinolone Acetonide | 35 | $391 | $11 |
| Ketoconazole | 13 | $304 | $23 |
2013: 4 drugs
| Fluocinonide | 28 | $1,523 | $54 |
| Ketoconazole | 69 | $1,371 | $20 |
| Clobetasol Propionate | 20 | $488 | $24 |
| Triamcinolone Acetonide | 29 | $395 | $14 |
Money from drug and device companies
$159 in 2025
| 2025 | 3 | 4 | None | $159 |
| 2024 | 12 | 28 | None | $769 |
| 2023 | 12 | 21 | None | $473 |
| 2022 | 13 | 22 | None | $529 |
| 2021 | 6 | 13 | None | $297 |
| 2020 | 6 | 6 | None | $137 |
| 2019 | 11 | 19 | None | $394 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Janssen Biotech | Tremfya | $108 | 2 payments
|
| Genzyme | Dupixent | $27 | 1 payment
|
| Abbvie | Skyrizi | $24 | 1 payment
|
See all 4 published payments
| Janssen Biotech | Meals · 2025-10-22 | Tremfya | $18 |
| Janssen Biotech | Education · 2025-07-15 | Tremfya | $90 |
| Abbvie | Meals · 2025-03-11 | Skyrizi | $24 |
| Genzyme | Meals · 2025-03-03 | Dupixent | $27 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $769
| Genzyme | Dupixent | $187 | 6 payments
|
| Abbvie | Skyrizi | $135 | 6 payments
|
| Janssen Biotech | Tremfya | $121 | 4 payments
|
| Regeneron Healthcare Solutions | Dupixent | $98 | 3 payments
|
| Biofrontera | Ameluz | $57 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $34 | 1 payment
|
| Incyte | Opzelura | $27 | 1 payment
|
| Amgen | Otezla | $26 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Spevigo | $26 | 1 payment
|
| Arcutis Biotherapeutics | Zoryve | $24 | 1 payment
|
| Galderma Laboratories L.P. | None | $19 | 1 payment
|
| Dermavant Sciences | Vtama | $16 | 1 payment
|
2023: $473
| Genzyme | Dupixent | $170 | 7 payments
|
| AbbVie | Rinvoq | $57 | 3 payments
|
| Janssen Biotech | Tremfya | $43 | 2 payments
|
| Regeneron Healthcare Solutions | Dupixent | $34 | 1 payment
|
| Biofrontera | Ameluz | $28 | 1 payment
|
| Amgen | Otezla | $28 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Spevigo | $25 | 1 payment
|
| Galderma Laboratories L.P. | None | $22 | 1 payment
|
| Pfizer | Eucrisa | $22 | 1 payment
|
| Lilly USA | Taltz | $20 | 1 payment
|
| Dermavant Sciences | Vtama | $18 | 1 payment
|
| Mayne Pharma Commercial | None | $6 | 1 payment
|
2022: $529
| Biofrontera | Ameluz | $91 | 3 payments
|
| Abbvie | Skyrizi | $67 | 3 payments
|
| Incyte | Opzelura | $58 | 2 payments
|
| Lilly USA | Taltz | $47 | 2 payments
|
| Janssen Biotech | Tremfya | $46 | 2 payments
|
| Almirall | Klisyri | $40 | 2 payments
|
| Genzyme | Dupixent | $38 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Spevigo | $27 | 1 payment
|
| LEO Pharma | Adbry | $26 | 1 payment
|
| Allergan | None | $24 | 1 payment
|
| Novartis Pharmaceuticals | Cosentyx | $24 | 1 payment
|
| Ucb | Cimzia | $22 | 1 payment
|
| Galderma Laboratories L.P. | None | $17 | 1 payment
|
2021: $297
| Allergan | Botox | $91 | 4 payments
|
| Pfizer | Eucrisa | $76 | 3 payments
|
| Janssen Biotech | Remicade | $61 | 3 payments
|
| Lilly USA | Taltz | $30 | 1 payment
|
| Genzyme | Dupixent | $20 | 1 payment
|
| Galderma Laboratories L.P. | None | $20 | 1 payment
|
2020: $137
| Biofrontera | Ameluz | $27 | 1 payment
|
| Sandoz | Kerydin | $24 | 1 payment
|
| Almirall | Seysara | $24 | 1 payment
|
| Allergan | Botox Cosmetic | $23 | 1 payment
|
| VYNE Pharmaceuticals | Amzeeq | $21 | 1 payment
|
| Pfizer | Eucrisa | $18 | 1 payment
|
2019: $394
| Novartis Pharmaceuticals | Cosentyx | $91 | 4 payments
|
| Sandoz | Kerydin | $49 | 2 payments
|
| Regeneron Healthcare Solutions | Dupixent | $37 | 1 payment
|
| Pfizer | Eucrisa | $36 | 2 payments
|
| Galderma Laboratories L.P. | Epiduo Forte | $36 | 2 payments
|
| LEO Pharma | Enstilar | $35 | 2 payments
|
| Biofrontera | Ameluz | $33 | 2 payments
|
| Lilly USA | Taltz | $25 | 1 payment
|
| Genzyme | Dermatitis - Disease | $19 | 1 payment
|
| Almirall | Seysara | $18 | 1 payment
|
| EPI Health | Sitavig | $15 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 98.8 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1689885279
- Licence
- CA 20A 9923
- Trained
- Lake Erie College of Osteopathic Medicine, Erie, 2002 · 24 years ago
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207N00000X (207N00000X)
- Mailing address
- Po Box 3704, Manhattan Beach, CA, 90266
- NPI first listed
- 2007-05-24
- NPI last updated
- 2018-06-26
This is when the NPI record was last certified, not a medical board exam.